The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...
Intermittent fasting is now the third most commonly practiced diet in the USA. Yet, despite more than 225 clinical trials—including nearly 40 in patients with diabetes or prediabetes—intermittent ...
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...
After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...
A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...
Everyday Health on MSN
Can GLP-1 drugs for obesity and diabetes also treat other diseases?
Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
GLP-1 receptor agonists are currently among the most widely discussed classes of drugs worldwide. They have gained popularity ...
A new study led by Marc D. Breton, PhD, found that a University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results